PubRank

Renaud Verdon

Author PubWeight™ 31.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One 2008 3.13
2 Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clin Infect Dis 2004 2.74
3 Better adherence with once-daily antiretroviral regimens: a meta-analysis. Clin Infect Dis 2009 1.94
4 Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial. J Clin Oncol 2007 1.49
5 Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication. Clin Infect Dis 2010 1.49
6 Antimicrobial stewardship and linezolid. Int J Clin Pharm 2014 1.44
7 Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance. BMC Med Res Methodol 2006 1.05
8 Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance. J Clin Virol 2005 1.03
9 Effect of twice-daily nevirapine on adherence in HIV-1-infected patients: a randomized controlled study. AIDS 2007 1.02
10 Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8). Int J Drug Policy 2007 0.98
11 Efavirenz to nevirapine switch in HIV-1-infected patients with dyslipidemia: a randomized, controlled study. Clin Infect Dis 2007 0.92
12 Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8). Qual Life Res 2007 0.91
13 Treatment resistance after sequential interruption of a non-nucleoside reverse transcriptase inhibitor-based regimen. AIDS 2007 0.89
14 Patterns of adherence to raltegravir-based regimens and the risk of virological failure among HIV-infected patients: the RALTECAPS cohort study. J Acquir Immune Defic Syndr 2012 0.89
15 Mechanisms of early virologic failure in antiretroviral-naive patients starting protease inhibitor-containing regimens: the APROVIR Study. J Infect Dis 2002 0.87
16 Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial. J Antimicrob Chemother 2011 0.87
17 Enterococcus gallinarum endocarditis occurring on native heart valves. J Clin Microbiol 2002 0.87
18 Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy. Int J Dermatol 2003 0.87
19 Draft Genome Sequence of Campylobacter coli Strain IPSID-1 Isolated from a Patient with Immunoproliferative Small Intestinal Disease. Genome Announc 2014 0.85
20 Lamivudine and indinavir/ritonavir maintenance therapy in highly pretreated HIV-infected patients (Vista ANRS 109). Antivir Ther 2006 0.83
21 Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapy. Antivir Ther 2012 0.81
22 Transient pituitary enlargement with central hypogonadism secondary to bilateral cavernous sinus thrombosis: pituitary oedema? Eur J Endocrinol 2009 0.81
23 "Rescue" bilateral adrenalectomy in paraneoplastic Cushing's syndrome with invasive Aspergillus fumigatus infection. Am J Med Sci 2007 0.81
24 A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients. J Antimicrob Chemother 2009 0.79
25 Impact of education and support on the tolerability and quality of life in a cohort of HIV-1 infected patients treated with enfuvirtide (SURCOUF Study). J Int Assoc Physicians AIDS Care (Chic) 2008 0.78
26 Pharmacokinetics of the treatment switch from efavirenz to nevirapine. Clin Infect Dis 2010 0.77
27 Disseminated intravascular coagulation as a manifestation of abacavir hypersensitivity reaction. AIDS 2002 0.76
28 HIV and HCV co-infection: situation at six French university hospitals in the year 2000. J Med Virol 2003 0.76
29 Pneumocystis jirovecii pneumonia in HIV-negative patients: a prospective study with focus on immunosuppressive drugs and markers of immune impairment. Scand J Infect Dis 2014 0.76
30 Thoracic splenosis mimicking a pleuropneumonia: A case report. Medicine (Baltimore) 2017 0.75
31 Late diagnosis and subsequent survival among HIV-infected truck drivers in the northwest of France: a retrospective study. AIDS 2009 0.75
32 Thrombophlebitis of the sigmoid sinus after tongue piercing: a case report. J Oral Maxillofac Surg 2007 0.75
33 [Vaccinations]. Rev Prat 2011 0.75